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Abstract Hormone-sensitive lipase (HSL) is a multi-functional 
enzyme involved in several aspects of lipid metabolism. Limited 
tryptic digestion of HSL led to selective loss of activity against 
lipid substrates but not against the water-soluble substrate, 
p-nitrophenyl butyrate. Following labelling of the active site 
of HSL with either [aH]di-isopropylfluorophosphate or
[14C]orlistat, tryptic digestion of HSL generated a stable 
radiolabelled domain of molecular mass approx. 17.6 kDa, 
consistent with this representing a catalytic domain of HSL 
capable of hydrolysing water-soluble but not lipid substrates. 
Following phosphorylation of HSL by cyclic AMP-dependent 
protein kinase, limited tryptic digestion produced a stable 
phosphorylated omain of molecular mass 11.5 kDa. Based on 
these experimental data a model for a domain structure of HSL 
is proposed. 
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I. Introduction 
Hormone-sensitive lipase (HSL) is the enzyme responsible 
for catalysing the initial steps of adipocyte lipolysis, and in 
addition has other diverse functions in lipid metabolism in a 
variety of tissues [1]. The enzyme, and in particular its regula- 
tion by reversible phosphorylation, has been studied exten- 
sively since it was initially identified over 30 years ago [2], 
but it is only relatively recently that details of the structure 
of the enzyme molecule have started to become available, and 
as yet very little is known about the molecular mechanism 
whereby HSL is activated by phosphorylation. 
The amino acid sequences of rat HSL, comprising 768 ami- 
no acid residues [3,4], and human HSL, comprising 786 amino 
acid residues [4] have been deduced from cDNA sequencing. 
Although it was reported initially that the protein sequence of 
HSL shows no similarity with any other sequenced eukaryotic 
protein [3], distant similarity with lipoprotein lipase has now 
been reported [5]. Furthermore, it has been demonstrated that 
HSL shares ignificant similarity (approx. 40% identity) with a 
lipase from the antarctic bacterium Moraxella TA144 [4,5] 
and with several other bacterial proteins including an esterase 
and two acetyl hydrolases [5,6]. This similarity is in the region 
including the putative active site serine at 423 and is approx. 
70 residues amino-terminal to the active site. Notwithstanding 
this recent information, the deduced protein sequence of HSL 
reveals very little information regarding the structure-function 
relationship of the enzyme. It does, however, allow the loca- 
tion of both phosphorylation sites to be assigned: site 1, the 
regulatory phosphorylation site is at Ser-563 in the rat HSL 
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sequence, while site 2, the basal phosphorylation site, is Ser- 
565 [7,8]. In addition, on the basis of similarity with other 
lipases and esterases, a GXSXG active-site motif was identi- 
fied at residues 421425 (GDSAG) and modification of Ser- 
423, followed by expression of HSL in COS cells has provided 
direct evidence that this serine residue is essential for catalytic 
activity [9]. 
HSL has a relatively broad substrate specificity, being not 
only capable of hydrolysing a variety of lipid substrates, but 
also having activity against he water-soluble substrate p-ni- 
trophenyl butyrate (PNPB) [I0]. Limited tryptic digestion of 
bovine HSL reduces the activity of the enzyme against lipid 
substrates to a greater extent than against PNPB, indicating 
the possible presence of a distinct lipid-binding site essential 
for activity against lipid substrates, consistent with data for 
other mammalian lipases [10]. We report here evidence for a 
multi-domain structure of HSL which will serve as a rational 
model on which to base future studies of the structure and 
regulation of this key enzyme. 
2. Materials and methods 
2.1. Materials 
Di[1,3-3H]isopropylfluorophosphate ([3H]DFP) was obtained from 
NEN and [y-32p]ATP from ICN Radiochemicals. Tri[3H]oleoyl - 
glycerol and l(3)-mono[3H]oleoyl-2-oleylglycerol (MOME) were 
kindly supplied by Prof. P. Belfrage (University of Lund, Sweden). 
[14C]Orlistat (formerly known as tetrahydrolipstatin) was a generous 
gift from Prof. A. Fischli (Hoffmann La Roche, Basel, Switzerland). 
Trypsin (L-l-tosylamido-2-phenylethylchloromethyl ketone(TPCK)- 
treated) was from Worthington. Soybean trypsin inhibitor (type I-S) 
and PNPB were from Sigma. Sources of other materials were as 
described in [11]. 
2.2. Enzyme preparations and assays 
The catalytic subunit of cyclic AMP-dependent protein kinase 
was purified to approx. 95% purity from bovine heart. Preparations 
of AMP-activated protein kinase from rat liver were generously pro- 
vided by the laboratory of Prof. D.G. Hardie (University of Dundee, 
UK). HSL was prepared from bovine adipose tissue essentially as de- 
scribed previously [11] except hat the final purification step (heparin- 
Sepharose) was replaced by chromatography on a Mono S FPLC 
column (Pharmacia, Uppsala, Sweden), followed by dialysis against 
buffer A (10 mM HEPES, pH 7.0, containing 0.I mM benzamidine, 
50% (w/v) glycerol, 1 mM dithiothreitol, 5 ~g/ml eupeptin, 0.2% (w/v) 
C1~E12). The enzyme was stored at -80°C. HSL was assayed against 
0.5 mM tri[3H]oleoylglycerol in ethanolic suspension based on the 
method in [12]. HSL activity against 1-[3H]MOME, a diacylglycerol 
analogue, was carried out in the presence of phospholipids as in [13]. 
Assays against he water-soluble substrate, PNPB, were performed 
essentially as in [14]. 
2.3. Limited tryptic digestion and labelling of HSL 
Limited tryptic digestion of HSL was carried out at pH 7.0 and 
25°C. Native HSL was digested at a final concentration f 10 ~g/ml 
protein by incubation for 15 min in the presence of 10 mM HEPES, 
pH 7.0, containing 10% (v/v) glycerol, 10 mM NaC1, 1 mM dithio- 
threitol and varying concentrations of trypsin. Digestion was termi- 
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n,tted by the addition of trypsin inhibitor to 20 Ixg/ml. Samples were 
immediately frozen in liquid nitrogen until subsequent assaying or 
rz(diolabelling. Samples of native HSL, or HSL which had been di- 
gested with trypsin as described above, were subjected to [3H]DFP 
labelling by adding to [3H]DFP (0.5 IxCi/nmol) to a final concentra- 
tion of 0.175 mM DFP and the samples incubated for 30 min at 30°C. 
"1 his treatment covalently modifies the enzyme and inhibits the activ- 
ity of HSL by greater than 95% [15]. Samples were then prepared for 
SDS-PAGE by precipitation of the protein with 20% (w/v) ice-cold 
t~ ichloroacetic acid and resuspension i 250 mM Tris-HC1, pH 6.8, 
¢ )ntaining 20% (w/v) glycerol, 4% (w/v) SDS, 5% (v/v) 2-mercap- 
t, ,ethanol, 0.002% (w/v) bromophenol blue. HSL was [32p]phos- 
paorylated by incubation for 15 min at 30°C in the presence of 
(~ 1 mM [7-3~P]ATP (1 /.tCi/nmol) and 5.4 mM MgC12. Phosphoryla- 
I on was catalysed by either 1.0 U/ml catalytic subunit of cyclic AMP- 
d,'pendent protein kinase or 1.4 U/ml AMP-activated protein kinase 
i~ the presence of 1.5 mM AMP. [32P]HSL was then subjected to 
limited tryptic digestion as described above. 
i ' 4. Electroblotting and sequence analysis 
SDS-PAGE was performed as in [16] using either 13.5 or 15% (w/v) 
r olyacrylamide r solving els. Proteins were electroblotted from gels 
(nto polyvinylidine diftuoride (PVDF) membranes (Pall Europe Ltd., 
1 ortsmouth, UK) for 4 h at 0.3 A using 10 mM CAPS (3-[cyclohex- 
: iamino]-l-propanesulphonic ac d), pH 11.0 in 10% (v/v) methanol. 
"l ransfer was complete as judged by the absence of Coomassie stain- 
i ~g of proteins on the original gel. The membranes were stained with 
1% (w/v) Coomassie Blue in 1% (v/v) acetic acid, 40°/,, (v/v) metha- 
i ol and destained with 50%, (v/v) methanol. The membranes were then 
t. ther subjected to direct autoradiography or the bands of interest 
, ere excised for sequence analysis on Applied Biosystems 470A gas- 
] hase and 477A pulsed liquid-phase protein sequencers using recom- 
1 tended reagents with 120A on-line phenylthiohydantoin (Pth)-amino 
~cid analysers [17]. Data collection and analysis were performed with 
', n Applied Biosystems 900A module calibrated with 25 pmol Pth- 
mino acid standards. 
: .  Results and discussion 
The water-soluble PNPB is an effective substrate for HSL, 
with maximum catalytic activity (150 U/mg) against hat sub- 
strate being approx. 10-fold higher than that against rioleoyl- 
glycerol under the assay conditions employed (not shown). 
Lineweaver-Burk analysis gave a Km of 0.21 mM for PNPB 
(a similar value has been reported in [10]) and an apparent K~ 
of 0.13 mM for trioleoylglycerol. 
Limited tryptic digestion of native HSL was found to re- 
duce dramatically the activity of the enzyme against rioleoyl- 
glycerol, whilst the activity against PNPB was relatively tryp- 
sin-insensitive (Fig. 1A). The differential effect of trypsin on 
these activities was such that after 15 min of digestion at 25°C 
with 2 gg/ml trypsin, approx. 75°/, of the PNPB hydrolase 
activity of HSL remained, whereas activity against trioleoyl- 
glycerol was reduced to less than 10% of the initial value. 
After digestion with 10 gg/ml, activity against trioleoylglycer- 
ol was virtually undetectable whilst that against PNPB was 
approx. 50% of the initial. Similarly, when the activities 
against the two different substrates were monitored as a func- 
tion of time of digestion with a fixed amount (2 p,g/ml) of 
trypsin, the activity against rioleoylglycerol decreased rapidly 
but the activity against PNPB was effectively retained (not 
shown). These results suggest that limited tryptic digestion 
of HSL selectively removes or destroys a region of the mole- 
cule responsible for binding lipid substrates, whilst a com- 
paratively stable catalytic region of the enzyme remains intact 
and is capable of hydrolysing water-soluble substrates. 
In order to investigate further this possibility, HSL was 
digested with the same range of trypsin concentrations and 
the resultant protein fragments were incubated with [3H]DFP 
in order to label specifically the active site of any fragments 
which retain catalytic activity. The labelled fragments were 
then separated by SDS-PAGE, electroblotted and analysed 
by direct autoradiography. The resultant autoradiograph 
showed the presence of several labelled fragments, which, 
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qg. 1. Limited tryptic digestion of HSL. Purified HSL (at a final concentration of 10 ~tg/ml HSL enzyme protein) was subjected to proteolytic 
Aigestion at pH 7.0 for 15 min at 25°C in the presence of the indicated concentration of trypsin as described in Section 2. Digestion of the pro- 
ein was terminated by the addition of trypsin inhibitor to 20 lig/ml. (A) Aliquots were then assayed in duplicate against ri[3H]oleoylglycerol 
~) or PNPB (D) as described. Results are expressed as a percentage of the activity observed in the absence of trypsin. Each point represents 
,he mean + S.E.M. for 5 separate xperiments. (B) Aliquots were incubated with 0.175 mM [3H]DFP for 30 min at 30°C as described in Section 
~. The protein fragments were then recovered by trichloroacetic acid precipitation, separated by SDS-PAGE, electroblotted and the radiola- 
belled polypeptides analysed by direct autoradiography. Lanes 2-9 each contain approx. 0.5 ~tg HSL enzyme protein and the indicated concen- 
1rations of trypsin: lanes: 1, control, buffer A+10 ~tg/ml; 2, undigested HSL; 3, 0.1 ktg/ml; 4, 0.2 Ixg/ml; 5, 0.3 ~tg/ml; 6, 0.6 ~tg/ml; 7, 1 ktg/ml; 
,~, 2 lag/ml; 9, 10 ~tg/ml. 
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with increasing digestion, are converted to the smallest radi- 
olabelled fragment of HSL (17.6 kDa) which is quite stable to 
tryptic digestion since increasing the final trypsin concentra- 
tion from 0.6 to 10 ~tg/ml had little effect on the intensity of 
this polypeptide band after autoradiography (Fig. 1B). 
[3H]DFP labelling of the 17.6 kDa fragment occurs under 
conditions in which activity against lipids has been lost, which 
indicates that the conformation of the active site of the en- 
zyme must remain stable within this fragment which is able to 
catalyse the hydrolysis of a water-soluble substrate and to 
react with DFP even though activity against triacylglycerol 
has been virtually eliminated. It appears, therefore, that the 
active site is contained within a relatively stable, putative cat- 
alytic domain (17.6 kDa) which may represent the minimum 
active unit which is required for esterase activity. 
Orlistat, formerly known as tetrahydrolipstatin, is a general 
lipase inhibitor derived from lipstatin, a lipid produced by 
Streptomyces toxytricini [18] and has been shown to inhibit 
in vitro several mammalian lipases including pancreatic lipase, 
gastric lipase and bile-salt activated lipase by binding at the 
active site [19,20]. When HSL was incubated with increasing 
concentrations of orlistat it was found that 1-10 mM orlistat 
caused approx. 90% loss of activity against lipid substrates 
and against PNPB (not shown). When HSL was incubated 
with [14C]orlistat, he 84 kDa polypeptide became radiola- 
belled (Fig. 2), and following limited tryptic digestion, the 
same stable domain of mass 17.6 kDa (as labelled with 
[3H]DFP) was detected following SDS-PAGE and autoradio- 
graphy (Fig. 2). Also, when HSL was subjected to limited 
proteolysis (as in Fig. 1) followed by incubation with 
[14C]orlistat, the same pattern of radiolabelling fragments 
was observed (Fig. 2) as with the labelling with [3H]DFP. 
When HSL was pre-incubated with increasing concentrations 
of non-radioactive orlistat prior to incubation with [3H]DFP, 
incorporation of radiolabel into the HSL polypeptide was 
blocked in a concentration-dependent manner (not shown). 
All the above observations are consistent with the presence 
of a single active site susceptible to modification by both DFP 
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Fig. 2. Covalent modification of HSL with [a4C]orlistat. Purified 
HSL (5 lal containing approx. 0.5 lag HSL enzyme protein) was 
radiolabelled with [a4C]orlistat (0.1 mM) as described in Fig. 1. 
[14C]HSL was then subjected to limited tryptic digestion (lanes 1~,) 
for 15 min at 25°C. In comparison, native HSL was subjected to 
limited tryptic digestion followed by [14C]orlistat labelling of the 
digestion fragments (lanes 5-8). Radiolabelled fragments were 
analysed as described in Section 2. Lanes: 1,5, control, buffer A+20 
lag/ml trypsin; 2,6, undigested HSL; 3,7, HSL+10 lag/ml trypsin; 
4,8, HSL+20 lag/ml trypsin. 
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Fig. 3. Limited digestion of [32p]HSL. Purified HSL (2 lal, contain- 
ing approx. 0.2 lag HSL enzyme protein) was phosphorylated with 
[)'-3ZP]ATP at the regulatory site by cyclic AMP-dependent protein 
kinase, as described in Section 2. [:12p]HSL was then subjected to 
limited tryptic digestion as in Fig. 1. Lanes 2 8 contained HSL plus 
the indicated amounts of trypsin. (A) Lanes: 1, control, buffer 
A+20 lag/ml trypsin; 2, undigested HSL; 3, 0.2 lag/ml; 4, 0.4 lag/ml; 
5, 2 lag/ml; 6, 4 lag/ml; 7, 10 lag/ml; 8, 15 lag/ml; 9, 20 lag/ml tryp- 
sin. 
and orlistat, the data in [9] further suggesting that this site of 
modification is Ser-423. 
To obtain a basis for more detailed structural studies of the 
HSL protein, the 17.6 kDa fragment was subjected to N-ter- 
minal sequence analysis after electroblotting. The sequence ob- 
tained was: LRPQQAPRSrALVVHIhGGgFVXQXS (amino 
acid residues hown in lower case are tentative assignments, X 
denotes no residue assigned). Only one Pth-amino acid residue 
was found at each cycle confirming the purity of the fragment. 
Comparison of this sequence with the predicted protein se- 
quence of rat [3] and human HSL [4] reveals that it corre- 
sponds to residues 333-358 in both sequences. The HSL se- 
quences how a high level of homology in this region, with, 
for example, only the N-terminal eucine in the bovine se- 
quence positively identified as being different from rat HSL 
(which has proline in this position). Based on an apparent 
mass of 17.6 kDa, the C-terminus of the tryptic fragment 
would be at approximately residue 498 (calculated using the 
rat HSL sequence with an average residue weight of 109.4). 
Since there is a Lys residue at position 499 in rat and human 
HSL, this is likely to represent the C-terminus of the frag- 
ment, although there are other potential tryptic cleavage sites 
in both rat and human HSL. Bovine HSL used here does 
indeed contain a Lys or Arg residue at position 499, since 
Holm et al. [3] obtained a tryptic peptide ALGVMGVQR 
which commences at position 500. Hence residue 499 is likely 
to be the C-terminal residue of this 17.6 kDa fragment. 
This work makes significant progress towards identifying 
the active site of HSL by eliminating approx. 80°/,, of the 
enzyme molecule, and localising its position to within a 17.6 
kDa domain. Interestingly, this putative catalytic domain of 
HSL contains the region exhibiting sequence similarity with 
the bacterial lipase. Although no direct evidence is available it 
is predicted that by analogy with the other lipases HSL will 
have a histidine and aspartic acid residue forming a catalytic 
triad with the active site serine at position 423. Identification 
of these additional catalytic residues will require either deter- 
mination of the three-dimensional structure of HSL (or of the 
putative catalytic domain) or alternatively site-specific muta- 
genesis of each histidine or aspartate residue. The 5 histidine 
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Fig. 4. Proposed omain structure of hormone-sensitive lipase. 
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motif 
;nd 7 aspartate residues within the catalytic domain of rat 
t ISL will provide an appropriate starting point for such a 
tudy. 
Although the phosphorylation sites on HSL have been 
tentified, little is known about the way changes in the phos- 
',,horylation state of the enzyme protein are expressed as 
hanges in enzyme activity. This prompted an investigation 
,f the effect of phosphorylation of the native enzyme at 
t,oth phosphorylation sites on the protein structure in order 
o shed some light on the mechanism of activation and on the 
potentially antilipolytic effect of phosphorylation at the basal 
-ite [21]. Following phosphorylation by cyclic AMP-depen- 
,lent protein kinase, radiolabelled HSL was subjected to lim- 
~Led tryptic digestion with increasing trypsin concentrations. 
~vlajor [32P]phosphoproteins were seen at 84 kDa (intact HSL) 
,:nd a doublet at approx. 13 and 11.5 kDa which, on further 
digestion, resolved into the lower of the two bands. It appears 
~hat the phosphorylated regulatory site is contained within a 
elatively stable domain of 11.5 kDa (Fig. 3) which may con- 
titute a regulatory domain within the HSL enzyme protein. 
\ttempts to exactly localise this domain within the enzyme 
~rotein by N-terminal amino acid sequencing of the fragment, 
n a similar way to that described for the putative catalytic 
,lomain, were unsuccessful, possibly due to some artefactual 
)locking of the fragment. 
However, when native HSL phosphorylated at the regula- 
ory site is digested by trypsin both the catalytic domain con- 
aining the active site residue (as detected by labelling with 
14C]orlistat) and the domain containing the phosphorylation 
.ites are recovered (compare Fig. 2, lane 3 and Fig. 3, lane 7), 
ndicating that there is no overlap in sequence between these 
tomains. Hence, the N-terminus of the phosphorylated do- 
nain must fall after the C-terminus of the catalytic domain 
approximately residue 499) but prior to the regulatory phos- 
>horylation site (Ser-563). 
In contrast o limited tryptic digestion of HSL phosphoryl- 
tted at the regulatory site, no stable phosphorylated domain 
~as produced following digestion of HSL phosphorylated at
he basal site by AMP-activated protein kinase, nearly all the 
"adioactivity being recovered in small phosphopeptides mi- 
• rating at the dye front (not shown). One possible xplanation 
"or this surprising observation is that phosphorylation of the 
>asal site produced a significant conformational change, ren- 
tering the phosphorylation domain more susceptible to pro- 
eolysis. Certainly the effects of phosphorylation at the two 
sites are very different in that phosphorylation of the regula- 
tory site activates the enzyme whilst phosphorylation at the 
basal site has no apparent effect on activity but blocks sub- 
sequent phosphorylation at the regulatory site [21]. 
The ability of the putative catalytic domain described above 
to hydrolyse PNPB, but not lipid substrates, indicates that a 
further region of HSL may be necessary for lipid binding. It 
has been suggested previously that such a region lies close to 
the C-terminus of the polypeptide [3,4]. Consistent with this, a 
stable polypeptide of approximate mass 11.0 kDa was de- 
tected following digestion of HSL with low levels of trypsin 
which cause loss of activity against lipid substrates. Amino 
acid sequencing of this fragment indicated that the first 11 
residues correspond to residues 658 668 in rat HSL (not 
shown). Based on 768 amino acids for intact rat HSL, the 
mass of approx. 11 kDa is consistent with this domain com- 
prising the residues from 658 to the carboxyl-terminus of the 
HSL polypeptide and containing the hydrophobic sequence 
(FLSLAALC) (residues 735 742 of rat HSL), proposed to 
represent a possible lipid-binding site [4]. Recently, analysis 
of the mouse gene for HSL has shown the presence of an exon 
(exon 9) which may encode this putative lipid-binding domain 
[22]. 
Taken together with previous work, the data presented have 
allowed a possible domain structure for HSL to be proposed 
(Fig. 4), which is amenable to further test and experimenta- 
tion. Of particular interest will be elucidation of a role for the 
35 kDa in the amino-terminal region, since the three key 
properties of HSL, namely catalytic activity, phosphorylation 
sites and lipid binding capacity, can be ascribed to the carbox- 
yl terminal region. One possible role for the N-terminal region 
would be in interacting with other regulatory components of 
the lipolytic and cholesterol metabolism pathways including 
possibly perilipin, a phosphoprotein implicated in HSL regu- 
lation [23]. 
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